pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
718
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
GSK-4382276A
Seasonal Influenza
$GSK
GSK plc
0
catalysts
Phase 2
GSK-5536522
Influenza A Virus, H5N1 Subtype Infections
$GSK
GSK plc
0
catalysts
Preclinical
Granzyme B Associated Peptide
Herpes Simplex Encephalitis
Biojenc LLC
0
catalysts
Phase 2
HB-adMSC Allogeneic
← prev
page 9 of 24
next →
131
Pain
89
Neurology
1
Crohn's Disease (Regional Enteritis)
Hope Biosciences LLC
0
catalysts
Phase 3
HB-adMSCs
Spinal Cord Injury
Hope Biosciences LLC
0
catalysts
Phase 1
HDT-321
Crimean-Congo Hemorrhagic Fever
HDT Bio Corp
0
catalysts
Preclinical
HIV Vaccine
Human Immunodeficiency Virus (HIV) Infections (AIDS)
DelSiTech Ltd
0
catalysts
Phase 1
HIV vaccine 3
Human Immunodeficiency Virus (HIV) Infections (AIDS)
The National Institute of Allergy and Infectious Diseases
0
catalysts
Phase 1
HNC-042
Unspecified Influenza Virus Infections
Guangzhou Henovcom Bioscience Co Ltd
0
catalysts
Preclinical
HNC-280
Hepatitis B
Guangzhou Henovcom Bioscience Co Ltd
0
catalysts
Phase 2
IIV-HD + rC19
Coronavirus Disease 2019 (COVID-19)
$SNY
Sanofi
0
catalysts
Phase 2
IMNN-101
Coronavirus Disease 2019 (COVID-19)
$IMNN
Imunon, Inc.
0
catalysts
Preclinical
IMTV-014
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Immgenuity Inc
0
catalysts
Phase 1
IN-001
Herpes Zoster (Shingles)
Innorna Co Ltd
0
catalysts
Preclinical
IN-002
Respiratory Syncytial Virus (RSV) Infections
Inhalon Biopharma Inc
0
catalysts
Preclinical
IN-003
Human Metapneumovirus Infections
Inhalon Biopharma Inc
0
catalysts
Phase 1
INO-8000
Hepatitis C
$INO
INOVIO PHARMACEUTICALS, INC.
0
catalysts
Preclinical
IR-101C
Coronavirus Disease 2019 (COVID-19)
Immune Response BioPharma Inc
0
catalysts
Preclinical
IS-101
InvisiMask
Coronavirus Disease 2019 (COVID-19)
InvisiShield Technologies Ltd
0
catalysts
Phase 2
JCXH-105
Herpes Zoster (Shingles)
Immorna Hangzhou Biotechnology Co Ltd
0
catalysts
Phase 2
JCXH-107
Seasonal Influenza
Immorna Hangzhou Biotechnology Co Ltd
0
catalysts
Phase 2
JCXH-221
Coronavirus Disease 2019 (COVID-19)
Immorna Hangzhou Biotechnology Co Ltd
0
catalysts
Phase 3
JNJ-69968054
Escherichia coli Infections
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 3
Jynneos
Smallpox
Bavarian Nordic AS
0
catalysts
Preclinical
KFPH-015
Influenzavirus A Infections
Jiangsu Carephar Pharmaceutical Co Ltd
0
catalysts
Phase 2
KL4 Surfactant
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Windtree Therapeutics Inc
0
catalysts
Phase 1
KSP-1007
Ventilator Associated Pneumonia (VAP)
Sumitomo Pharma Co Ltd
0
catalysts
Marketed
Kimyrsa
Kimyrsa (oritavancin [INN])
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
Melinta Therapeutics LLC
0
catalysts
Phase 2
LACTIN-V
Bacterial Vaginosis
Osel Inc
0
catalysts
Phase 2
LBPEC-01
Escherichia coli Infections
Locus Biosciences Inc
0
catalysts
